Fugoso, Joy E.
HRN: 22-75-16 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/12/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
02/12/2025
02/14/2025
IV
500mg
Every 12 Hours
S/P LTCS
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes